U.S. authorizes Pfizer oral COVID-19 treatment, first for at-home use
The United States on Wednesday authorized Pfizer Inc’s (PFE.N) antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first oral treatment and which can be taken Continue Reading
